retatrutide clinical trial results 2024 2025 press release Phase III study demonstrates 30% weight loss Incretin-based therapies for the treatment

Debunking GLP-1 Myths: The Truth About Medical Weight Loss

Clinical trial evidence from SURMOUNT-1 The landmark SURMOUNT-1 trial, published by Jastreboff and colleagues, provided some of the cleanest data on tirzepatide and hair loss

Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency

Contact your doctor immediately if you experience more than six loose stools daily for over 48 hours, blood in stools, severe abdominal pain, fever above 100.4F, signs of dehydration (decreased urination, dizziness, confusion), or inability to keep down fluids

It works across multiple areas of the face, such as the cheeks, chin, and forehead